Multiple inhibitory effects of Alzheimer's peptide A beta 1-40 on lipid biosynthesis in cultured human HepG2 cells

被引:28
作者
Koudinova, NV
Berezov, TT
Koudinov, AR
机构
[1] RUSSIAN ACAD MED SCI,MOSCOW 117198,RUSSIA
[2] NYU MED CTR,DEPT MED,NEW YORK,NY 10016
关键词
amyloid beta protein; apolipoprotein; Alzheimer's disease; Down's syndrome; lipid biosynthesis; lipoprotein;
D O I
10.1016/0014-5793(96)01042-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Herein we describe the inhibitory effect of the synthetic peptide A beta 1-40, homologous to the major high-density lipoprotein-associated species of Alzheimer's amyloid beta protein (A beta), on lipid biosynthesis in human hepatic HepG2 cells. This culture synthesizes various lipids from [C-14]acetate as a precursor. Treatment of cells with different concentrations of A beta 1-40 decreased the syntheses of various radiolabeled lipid species. The decrease reached saturation at peptide concentrations equal to 10-100 ng ml(-1). The lipids whose synthesis was decreased most mere free and esterified cholesterol and phospholipids. This inhibitory effect suggests that A beta protein may modulate physiological intracellular lipid syntheses. It may also be of special importance in the pathological condition, and contribute to the neurodegeneration, in Alzheimer's disease and related disorders.
引用
收藏
页码:204 / 206
页数:3
相关论文
共 30 条
[1]  
BEREZOV T, 1992, BIOCHEMISTRY-US, P257
[2]   IDENTIFICATION OF AMYLOID-BETA PROTEIN IN THE BRAIN OF THE SMALL, SHORT-LIVED LEMURIAN PRIMATE MICROCEBUS-MURINUS [J].
BONS, N ;
MESTRE, N ;
RITCHIE, K ;
PETTER, A ;
PODLISNY, M ;
SELKOE, D .
NEUROBIOLOGY OF AGING, 1994, 15 (02) :215-220
[3]   APOLIPOPROTEIN E-4 GENE DOSE IN CLINICALLY DIAGNOSED ALZHEIMERS-DISEASE - PREVALENCE, PLASMA-CHOLESTEROL LEVELS AND CEREBROVASCULAR CHANGE [J].
CZECH, C ;
FORSTL, H ;
HENTSCHEL, F ;
MONNING, U ;
BESTHORN, C ;
GEIGERKABISCH, C ;
SATTEL, H ;
MASTERS, C ;
BEYREUTHER, K .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1994, 243 (05) :291-292
[4]  
FIELDING CJ, 1995, J LIPID RES, V36, P211
[5]   EVIDENCE FOR A MEMBRANE LIPID DEFECT IN ALZHEIMER-DISEASE [J].
GINSBERG, L ;
ATACK, JR ;
RAPOPORT, SI ;
GERSHFELD, NL .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1993, 19 (1-2) :37-46
[6]   REGIONAL SPECIFICITY OF MEMBRANE INSTABILITY IN ALZHEIMERS-DISEASE BRAIN [J].
GINSBERG, L ;
ATACK, JR ;
RAPOPORT, SI ;
GERSHFELD, NL .
BRAIN RESEARCH, 1993, 615 (02) :355-357
[7]   LIPID EXTRACTION OF TISSUES WITH A LOW-TOXICITY SOLVENT [J].
HARA, A ;
RADIN, NS .
ANALYTICAL BIOCHEMISTRY, 1978, 90 (01) :420-426
[8]   INTERACTIONS OF APOLIPOPROTEIN-E GENOTYPE, TOTAL CHOLESTEROL LEVEL, AGE, AND SEX IN PREDICTION OF ALZHEIMERS-DISEASE - A CASE-CONTROL STUDY [J].
JARVIK, GP ;
WIJSMAN, EM ;
KUKULL, WA ;
SCHELLENBERG, GD ;
YU, C ;
LARSON, EB .
NEUROLOGY, 1995, 45 (06) :1092-1096
[9]   HEP-G2 CELLS AS A RESOURCE FOR METABOLIC STUDIES - LIPOPROTEIN, CHOLESTEROL, AND BILE-ACIDS [J].
JAVITT, NB .
FASEB JOURNAL, 1990, 4 (02) :161-168
[10]  
KLIMOV A, 1994, LIPIDS LIPOPROTEINS, P95